RAPT Therapeutics Inc. (NASDAQ:RAPT) announced that it has decided to close and unblind both its Phase 2b trial of ...

Systemic antibiotic exposure in the first year of life is associated with higher atopic dermatitis (AD) risk in a ...

Katie Couric, Kerry Washington, Elle Fanning, and other famous women all live with this common form of eczema. Read on for their stories and coping strategies.

What's perioral dermatitis? Two dermatologists explain more about the condition, including perioral dermatitis causes, ...

Researchers say a new "tailored" vaccine shows promise in treating eczema flares caused by a certain bacteria in children ...

If you have atopic dermatitis (AD), you’ll recognize this description of symptoms from Jenny Murase, M.D., an associate clinical professor at the University of California, San Francisco and ...

The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for tapinarof cream, 1% for the topical treatment of atopic dermatitis (AD) in adults and children 2 ...

Eczema, also known as atopic dermatitis, affects up to one in four children in Ireland. Common symptoms include itchy, dry ...

Researchers at MIT, Brigham and Women's Hospital, and Harvard Medical School have developed a potential new treatment for ...

Enrollment ongoing for global Phase 2b trial to treat atopic dermatitis (AD) with ANB032, our BTLA agonist; reiterating top-line data anticipated ...

Galderma today announced that it has received filing acceptances for nemolizumab for the treatment of patients with prurigo nodularis and for adolescents and adults with moderate-to-severe atopic ...

The immunology-based therapeutics company said it has decided to close and unblind both its Phase 2b clinical trial of zelnecirnon in atopic dermatitis and its Phase 2a trial of zelnecirnon in asthma.